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Introduction
Despite long-held dogma on the impossibility of changing the 
identity of differentiated cells, the expression of specific transcrip-
tion factors, cell-cell fusion, and nuclear transfer experiments has 
shown the feasibility of reprogramming cellular identity toward 
both pluripotency and unrelated cell fates (1–5). Neurons are still 
considered among the most immutable cell types; nevertheless, 
recent studies have demonstrated that resident nonneuronal cells 
can be reprogrammed into induced neurons in vivo (6). This sug-
gests that self-repair of nervous tissue can be promoted by induc-
ing the fate conversion of resident cells into the desired cell type. 
Glial cells show the potential to divide and are very abundant in 
nervous tissue; therefore, they have been proposed as the ideal 
candidate cell type to generate new neurons. Glial cells can be 
turned into morphologically identifiable neurons in adult stria-
tum upon expression of a cocktail of transcription factors (7) or 
just by the overexpression of Sox2, passing through an intermedi-
ate neuroblast stage (8).
In vivo conversion of glial cells into neurons represents a 
self-healing mechanism to regenerate nervous tissue in some 
species. Müller glia (MG) is the major glial cell type in the retina, 
is common to all vertebrates, and normally contributes to reti-
nal structure and homeostasis (9). After an injury, zebrafish MG 
dedifferentiates and generates proliferating multipotent neural 
progenitors, which in turn exit the cell cycle and redifferentiate, 
replacing all lost retinal cell types with sight restoration (10–12). In 
mammals, MG normally responds to damage by becoming reac-
tive and undergoing gliosis (13, 14). However, some studies have 
indicated that a limited numbers of mouse and rat MG can reenter 
the cell cycle and be converted into retinal neurons after retinal 
injury and upon stimulus induction or expression of specific fac-
tors (15–18). These early studies made some pioneering obser-
vations; however, direct conversion of MG into neurons can be 
definitely concluded only with lineage-tracing experiments (19). 
Overall, the efficiency of the reported conversion was low or was 
not quantified, and importantly, electrophysiological functionality 
of the neurons obtained was not investigated. Nevertheless, these 
results suggest that the barrier that blocks MG reprogramming can 
also potentially be overcome in mammals.
Interestingly, the activation of Wnt/β-catenin signaling can 
mediate proliferation of MG in the injured mammalian retina 
(16). Wnt/β-catenin signaling strongly enhances the efficiency of 
reprogramming of somatic cells upon cell fusion with pluripotent 
stem cells (20, 21). Transplanted BM-derived cells (BMDCs) can 
fuse with somatic cells and generate hybrids, which in turn can 
differentiate in myocytes (22), hepatocytes (23), neurons (24, 25), 
and other cell types in vivo (26, 27). We recently showed that, upon 
drug-induced ganglion cell (GC) damage, transplanted Wnt-acti-
vated hematopoietic stem and progenitor cells (HSPCs) can fuse 
with retinal cells. The newly formed hybrids undergo reprogram-
ming and differentiate into ganglion and amacrine neurons (28).
Vision impairments and blindness caused by retinitis pigmentosa result from severe neurodegeneration that leads to a loss 
of photoreceptors, the specialized light-sensitive neurons that enable vision. Although the mammalian nervous system 
is unable to replace neurons lost due to degeneration, therapeutic approaches to reprogram resident glial cells to replace 
retinal neurons have been proposed. Here, we demonstrate that retinal Müller glia can be reprogrammed in vivo into retinal 
precursors that then differentiate into photoreceptors. We transplanted hematopoietic stem and progenitor cells (HSPCs) 
into retinas affected by photoreceptor degeneration and observed spontaneous cell fusion events between Müller glia and 
the transplanted cells. Activation of Wnt signaling in the transplanted HSPCs enhanced survival and proliferation of Müller-
HSPC hybrids as well as their reprogramming into intermediate photoreceptor precursors. This suggests that Wnt signaling 
drives the reprogrammed cells toward a photoreceptor progenitor fate. Finally, Müller-HSPC hybrids differentiated into 
photoreceptors. Transplantation of HSPCs with activated Wnt functionally rescued the retinal degeneration phenotype in 
rd10 mice, a model for inherited retinitis pigmentosa. Together, these results suggest that photoreceptors can be generated by 
reprogramming Müller glia and that this approach may have potential as a strategy for reversing retinal degeneration.
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fuse with MG in a drug-induced mouse model of photoreceptor 
degeneration. We used Gfap-Cre recipient mice (expressing Cre 
recombinase under the long form of the Gfap promoter), which 
restrict expression of Cre to MG (19, 29). Indeed, by using the lin-
eage-tracing model that expresses yellow fluorescent protein (YFP) 
to track MG, we confirmed the exclusive colocalization of YFP with 
the MG marker glutamine synthase (GS) and not with PKC-α (a 
marker of bipolar cells), recoverin (a marker of photoreceptors), 
calbindin (a marker of horizontal cells), calretinin (a marker of 
amacrine and GCs), or neurofilament, heavy polypeptide (NEFH) 
and β-tubulin III (markers of GCs) (Supplemental Figure 1A; sup-
plemental material available online with this article; doi:10.1172/
JCI85193DS1). We treated Gfap-Cre recipient mice with N-methyl-
 N-nitroso urea (MNU), which induces progressive photoreceptor 
cell death (TUNEL+) within 24 hours (Figure 1, A and B, and Sup-
plemental Figure 1, B and C; compare WT with MNU/PBS) and 
complete degeneration of the outer nuclear layer (ONL), where 
By taking into account all of these previous observations, we 
here hypothesize that MG can be reprogrammed in vivo via cell 
fusion and become a source of new photoreceptors. In the present 
study, we demonstrate that Wnt-activated HSPCs transplanted in 
the retina of mouse models of genetic and drug-induced photo-
receptor degeneration can fuse with MG with high efficiency. We 
found cell fusion to be the functional way through which MG reen-
ters the cell cycle, proliferates, is reprogrammed back to a pluri-
potent/neural progenitor–like state, and finally differentiates into 
photoreceptors. Electrophysiological rescue and retinal regenera-
tion are observed, which suggest that MG reprogramming and the 
subsequent differentiation into photoreceptors via cell fusion is a 
possible strategy for treatment of retinitis pigmentosa.
Results
MG cells fuse with transplanted HSPCs upon photoreceptor degener-
ation. We aimed to determine whether transplanted HSPCs can 
Figure 1. Transplanted HSPCs fuse with MG 
upon photoreceptor damage. (A) Schematic 
representation of the experimental plan. Cell 
fusion between HSPCs isolated from LoxP-
STOP-LoxP-YFP donor mice (R26Y) and recipient 
Gfap-Cre MG cells leads to excision of the floxed 
stop codon and, in turn, to the expression of YFP. 
(B) Representative coimmunostaining of YFP+ 
hybrids (green) and TUNEL+ (red) apoptotic pho-
toreceptors on retinal sections harvested from 
MNU-damaged or healthy (control) Gfap-Cre 
eyes 12 hours after subretinal transplantation of 
HSPCsR26Y. YFP+ hybrids (green) derived from cell 
fusion are detected in MNU-damaged retinas, 
which show TUNEL+ photoreceptors in the ONL, 
but not in the undamaged eyes (control). Nuclei 
were counterstained with DAPI (blue). Scale 
bar: 20 μm. n = 3. (C) Statistical analysis of the 
percentage of DiD+YFP+ hybrids evaluated on the 
total amount of DiD-labeled HSPCsR26Y detected 
by FACS analysis in MNU-damaged or healthy 
(control) Gfap-Cre retinas 24 hours after trans-
plantation. Data are represented as mean ± SD of 
3 independent experiments. n = 3. ***P < 0.0001 
by unpaired Student’s t test. (D) Representa-
tive immunostaining of YFP+ hybrids (green) 
also positive for the MG marker (GS, red; yellow 
arrows) but not for the photoreceptor marker 
recoverin (red; green arrow) detected 24 hours 
after transplantation of HSPCsR26Y in MNU-dam-
aged Gfap-Cre retinas. Scale bar: 20 μm. n = 3. 
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and B, and Supplemental Figure 1D). The YFP+ hybrids localized 
radially across the thickness of the retina, which is typical of MG 
morphology. YFP+ hybrids were detected upon transplantation in 
MNU-damaged retinas, where many photoreceptors were apoptot-
ic (Figure 1B, TUNEL+), but they were not appreciable in sections 
where HSPCsR26Y were transplanted into nondamaged Gfap-Cre 
eyes, which suggests that photoreceptor cell death is necessary to 
induce cell fusion (Figure 1B). A mean of 5.9% ± 1.5% of the total 
transplanted DiD-labeled HSPCsR26Y was also YFP+ when inject-
photoreceptors are localized, after 7 days (30, 31). Twenty-four 
hours after MNU damage, we injected HSPCs isolated from LoxP-
STOP-LoxP-YFP (R26Y) transgenic donor mice into the subretinal 
space of Gfap-Cre recipient eyes, close to the layer of damaged pho-
toreceptors. Gfap-Cre mice not treated with MNU were also trans-
planted as controls. Twelve hours after HSPCsR26Y transplantation, 
we detected many YFP+ cells close to the site of the injection; this 
was due to the stop codon excision by Cre after fusion of HSPCsR26Y 
with Müller cells from Gfap-Cre mice (MGGfap–Cre) (Figure 1, A 
Figure 2. Activation of Wnt signaling 
promotes proliferation and survival 
of hybrids. (A and B) Percentages of 
proliferating (PCNA+, A) or apoptotic 
(TUNEL+, B) YFP+ hybrids on the total 
amount of YFP+ hybrids in MNU-dam-
aged Gfap-Cre retinas 24 hours 
after transplantation of untreated 
(HSPCs) or BIO-treated (BIO-HSPCs) 
HSPCsR26Y. ***P < 0.0001, unpaired 
Student’s t test. (C) qPCR analysis 
of cell-cycle genes on FACS-sorted 
DiD+YFP+ hybrids harvested 24 hours 
after transplantation of untreated or 
BIO-treated HSPCsR26Y in MNU-dam-
aged Gfap-Cre retinas. Data are 
represented as mean ± SD of log10 fold 
changes of gene expression in DiD+ 
YFP+ hybrids with respect to DiD+YFP+ 
population-depleted retinas. n = 3. 
(D) Total YFP+ hybrids (green bars) 
that also incorporated BrdU (red bars) 
detected in MNU-damaged Gfap-Cre 
retinas 24 hours, 72 hours, and 1 week 
after transplantation of untreated or 
BIO-treated HSPCsR26Y. **P < 0.001, 
2-way ANOVA and Bonferroni’s post-
test. Red and green lines show the 
statistical significance of green (YFP) 
or red (BrdU) bars. (E–G) Percentages 
of YFP+BrdU+ hybrids also positive 
for GS (E, Müller cells), OTX2 (F, 
photoreceptor progenitors), or recov-
erin (G, REC, mature photoreceptors) 
detected in MNU-damaged Gfap-Cre 
retinas 24 hours, 72 hours, and 1 week 
after transplantation of untreated or 
BIO-treated HSPCsR26Y. (H–J) Repre-
sentative immunostainings of double 
YFP+ (green)/BrdU+ (red) hybrids also 
positive for either GS (magenta in H, 
white arrowheads), OTX2 (magenta 
in I, yellow arrowheads), or recoverin 
(magenta in J, green arrowheads) 
stainings in MNU-damaged Gfap-Cre 
retinas 24 hours (H), 72 hours (I), and 
1 week (J) after transplantation of 
BIO-treated HSPCs. Nuclei were coun-
terstained with DAPI (blue). Images on 
the top show higher magnification and 
single channels of areas in the white 
squares. Scale bars: 20 μm. (A, B, and 
D–G) Values in graphs are represented 
as mean ± SD (n = 9).
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eyes, where a mean of 7.5% ± 1.2% DiD+YFP+ 
hybrids was found 24 hours after transplantation, 
but only in the damaged group (Supplemental Fig-
ure 1, F–H; HSPCs/R26Y).
Given that we obtained approximately the 
same percentages of hybrids after transplanta-
tion into R26Y or into Gfap-Cre recipient mice 
(Supplemental Figure 1H), we hypothesized that 
HSPCsVav-Cre fused mainly with MG upon photo-
receptor damage. Furthermore, YFP+ hybrids 
were immunoreactive to the MG marker GS, but 
not to the photoreceptor marker recoverin (Fig-
ure 1D), which further suggests fusion of HSPCs 
with MG. Finally, almost no YFP+ hybrids were 
identified in both damaged and undamaged 
retinas harvested 24 hours after transplanta-
tion of DiD-labeled HPSCs from R26Y mice 
(HSPCsR26Y) either in recipient mice carrying Cre 
under the photoreceptor-specific rhodopsin pro-
moter (Rho-Cre; ref. 32) or in recipient mice car-
rying Cre under the ganglion- and amacrine-specific calretinin pro-
moter (Calr-Cre; ref. 33), thus excluding major fusion of transplanted 
HSPCs with other retinal cell types (Supplemental Figure 1, H–J). 
Taken together, these results indicate that HSPCs can fuse almost 
exclusively with MG when transplanted in the subretinal space of an 
MNU-induced mouse model of photoreceptor degeneration.
MG reenters the cell cycle upon fusion with HSPCs through a 
Wnt-dependent process. MG can reenter the cell cycle after retinal 
damage (14). Furthermore, we previously demonstrated that Wnt 
signaling enhances the proliferation of hybrids formed in vitro 
and in vivo (20, 28). Thus, we investigated whether MG-derived 
hybrids can reenter the cell cycle upon Wnt activation. We trans-
planted into the eyes of MNU-damaged Gfap-Cre mice either 
HSPCsR26Y, where the Wnt signaling pathway was preactivated 
by the GSK-3 inhibitor 6-bromoindirubin-3′-oxime (BIO) (Sup-
ed into MNU-damaged eyes (DiD+YFP+ hybrids; Figure 1C and 
Supplemental Figure 1, E and H; Gfap-Cre), which corresponds 
to the frequency of cell-fusion events. However, a few YFP+DiD– 
hybrids (not included in the analysis) were also found; thus, we 
cannot exclude an underestimation of fusion frequency. In con-
trast, we observed very few hybrids (detectable only by FACS 
analysis and likely due to the mechanical damage induced by 
the injection) when DiD-labeled HSPCsR26Y was transplanted 
into nondamaged (control) Gfap-Cre recipient eyes (Figure 1C 
and Supplemental Figure 1H; Gfap-Cre, see below), thus con-
firming that cell fusion between HSPCs and MG can occur in the 
presence of tissue damage.
Cell fusion was also confirmed by transplanting DiD-labeled 
HSPCs expressing Cre under the BM-specific promoter Vav (referred 
to here as HSPCsVav-Cre) into MNU-damaged and nondamaged R26Y 
Figure 3. Activation of Wnt signaling promotes 
reprogramming of hybrids. (A) Gene expression 
analysis of pluripotent (blue bars), neural progeni-
tor (red bars), photoreceptor progenitor (black bars), 
mature photoreceptor (green bars), and differentiated 
cell (orange bars) markers in DiD+YFP+ hybrids. The 
hybrids were FACS sorted 24 hours, 72 hours, and 1 
week after transplantation of untreated or BIO-treated 
HSPCsR26Y in MNU-damaged Gfap-Cre retinas. Data 
represent the mean of log10 fold changes ± SEM of gene 
expression detected in hybrids obtained upon fusion 
with BIO-treated DiD-HSPCs with respect to hybrids 
obtained upon fusion with untreated DiD-HSPCs. n = 3. 
(B) Schematic representation of the experimental plan 
to detect dedifferentiation of retinal cells upon fusion. 
Reactivation of the nestin promoter in retinal cells 
fused with transplanted HSPCsR26Y leads to Cre expres-
sion and the consequent formation of YFP+ hybrids. (C) 
Representative immunostaining of YFP+ hybrids (green) 
and TUNEL+ apoptotic photoreceptors (red) on retinal 
sections obtained from MNU-damaged nestin-Cre 
retinas 24 hours after transplantation of untreated or 
BIO-treated HSPCsR26Y. Nuclei were counterstained with 
DAPI (blue). Scale bar: 20 μm.
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We then investigated the expression levels of different 
cell-cycle regulators in hybrids that were FACS sorted 24 hours 
after transplantation of BIO-treated or untreated HSPCsR26Y in 
MNU-damaged Gfap-Cre eyes. Cyclin D1, which is expressed 
in mitotic retinal progenitor cells and is required for progenitor 
cell proliferation (34, 35), was strongly upregulated in hybrids 
formed after transplantation of both BIO-treated and untreated 
HSPCs (Figure 2C). We also found upregulation of p21(Cip1/WAF1), 
which is correlated with neural stem cell maintenance and tis-
sue regeneration (36). Interestingly, the cyclin kinase inhibitors 
p27kip1, which is downregulated in activated MG (37), and p57kip2, 
which is associated with cell-cycle exit of retinal progenitor 
cells (14), were both downregulated in hybrids obtained after 
transplantation of BIO-treated HSPCs (Figure 2C), which sug-
gests the prolonged proliferative potential of the BIO hybrids. 
These observations indicate that some cell-cycle genes are 
plemental Figure 2A), or nonactivated HSPCsR26Y. We found YFP+ 
hybrids that were also positive for the proliferation marker pro-
liferating cell nuclear antigen (PCNA) in sections of retinas har-
vested 24 hours after transplantation of HSPCsR26Y (Figure 2A and 
Supplemental Figure 2B, HSPCs). However, the majority of these 
embarked upon apoptosis, as more than 35% of YFP+ cells were 
also positive for TUNEL staining (Figure 2B and Supplemental 
Figure 2, C and D, HSPCs). In contrast, more PCNA+ hybrids were 
detected 24 hours after transplantation of BIO-treated HSPCs 
(Figure 2A and Supplemental Figure 2B, BIO-HSPCs) and only 
a few YFP+ hybrids underwent apoptosis (Figure 2B and Supple-
mental Figure 2, C and D, BIO-HSPCs). These results suggest that 
preactivation of Wnt signaling in HSPCs enhances the survival 
and proliferation of hybrids formed upon fusion with MG. Of note, 
Wnt activation did not increase the fusion efficiency (Supplemen-
tal Figure 2E; compare HSPCs with BIO-HSPCs).
Figure 4. MG reprogrammed upon 
fusion with Wnt-activated HSPCs 
generates new photoreceptors. (A and 
B) Representative immunostainings of 
YFP+ (green) hybrids also immunoreac-
tive for either GS (red, white arrows) or 
recoverin (red, yellow arrows) detected in 
MNU-damaged Gfap-Cre retinas 1 week 
after transplantation of untreated (A) or 
BIO-treated (B) HSPCsR26Y. Nuclei were 
counterstained with DAPI (blue). n = 3. 
(C) Statistical analysis of the number of 
photoreceptor nuclear rows in the ONL 
of healthy (WT) or MNU-damaged eyes 
1 week after treatment with either PBS 
or untreated (HSPCs) or BIO-treated 
HSPCs (BIO-HSPCs) or BIO alone. Data 
are represented as mean ± SD counted 
in 3 different sections spanning the site 
of the injection for each mouse. n = 9. 
***P < 0.0001, unpaired Student’s t test. 
(D) Representative immunodetection 
of BrdU-positive cells (red) also positive 
for the photoreceptor marker recoverin 
(green) in the ONL of MNU-damaged 
Gfap-Cre retinas 1 week after transplan-
tation of BIO-treated HSPCsR26Y. Nuclei 
were counterstained with DAPI (blue). 
Insert represents a higher magnification 
of the region in the white square. (n = 3). 
Scale bars: 20 μm.
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perturbed in both types of hybrids; however, the activation of 
HSPCs with BIO provides a proliferative advantage.
To further analyze the fate of the proliferating hybrids, we inject-
ed BrdU twice every 12 hours in MNU-damaged Gfap-Cre mice that 
were transplanted with untreated or BIO-treated HSPCsR26Y. Thus, 
we analyzed YFP+ hybrids that incorporated BrdU 24 hours, 72 
hours, and 1 week after transplantation. Although the total number 
of YFP+ hybrids detected in each retinal section was similar 24 hours 
after transplantation of either untreated or BIO-treated HPSCs, Wnt 
signaling activation resulted in more hybrids that incorporated BrdU 
(Figure 2D), which indicates their proliferative advantage. Interest-
ingly, 72 hours and 1 week after transplantation of untreated HSPCs, 
the total number of YFP+ hybrids was reduced, which suggests that 
hybrids that did not proliferate (i.e., YFP+BrdU– cells) possibly died 
(Figure 2D). In contrast, the number of double-positive BrdU+YFP+ 
cells as well as the number of total YFP+ hybrids increased 72 hours 
and 1 week after transplantation of BIO-treated HSPCs, which 
suggests that upon activation of Wnt signaling, some proliferating 
BrdU+YFP+ hybrids had moved into and through a new M phase and 
survived. Moreover, we also detected a higher number of YFP+BrdU– 
cells 72 hours and 1 week after transplantation of BIO-HSPCs, with 
respect to those counted 24 hours after transplantation (Figure 2D), 
which suggests that either some proliferating hybrids did not incor-
porate BrdU or that they underwent multiple divisions and thus lost 
the BrdU. Together, these results suggest that activation of Wnt sig-
naling in transplanted HSPCs promotes proliferation and survival of 
hybrids formed after fusion with MG.
MG is reprogrammed in vivo after fusion with Wnt-activated 
HSPCs, and the hybrids differentiate into photoreceptors. We aimed 
to determine whether MG is reprogrammed in vivo upon fusion 
with Wnt-activated HSPCs. Interestingly, we observed that, while 
the majority of the proliferating YFP+BrdU+ hybrids were positive 
for the MG marker GS 24 hours, 72 hours, and 1 week after trans-
plantation of untreated HSPCs, the percentage of YFP+BrdU+ 
hybrids positive for GS was drastically reduced 72 hours and 1 
week after transplantation of BIO-HSPCs (Figure 2, E and H, see 
below) and the latter were mainly positive for the expression of 
the photoreceptor progenitor marker orthodenticle homeobox 2 
(OTX2) at 72 hours after transplantation (Figure 2, F and I, see 
below). Furthermore, we noted that the photoreceptor marker 
recoverin started to be expressed in the YFP+BrdU+ hybrids 72 
hours after transplantation of BIO-HSPCs and that all the Brdu+ 
YFP+ cells expressed recoverin 1 week after transplantation (Fig-
ure 2, G and J, see below). Of note, the proliferating hybrids (i.e., 
double YFP+BrdU+ hybrids) were mainly localized in the ONL 
already at 24 hours (Figure 2H), when they expressed MG mark-
ers, and consequently, at late time points (Figure 2J, see below), 
when they differentiated toward photoreceptors, which indicates 
their movement toward the ONL. These results suggest that 
Wnt signaling promotes the reprogramming of the proliferating 
hybrids toward a photoreceptor progenitor fate.
To further strengthen these results, DiD+YFP+ hybrids were FACS 
sorted 24 hours, 72 hours, and 1 week after transplantation of DiD- 
labeled BIO-HSPCsR26Y or untreated DiD-HSPCsR26Y in MNU-dam-
aged Gfap-Cre eyes. The gene expression profiles were analyzed (Fig-
ure 3A). Twenty-four hours after transplantation, pluripotent markers 
(Oct4, Nanog, and Fbx15) were upregulated in the hybrids obtained 
after fusion of BIO-HSPCs and progressively silenced 1 week after 
transplantation. The Wnt target Axin2 was also upregulated in the 
hybrids 24 hours after transplantation of BIO-HSPCs, which indi-
cates activation of Wnt signaling (Supplemental Figure 3A). In con-
trast, neural progenitor markers (Nestin, Foxd3, Six6, Six3, and Pax6) 
were upregulated up to 72 hours after transplantation, while they were 
silenced in 1 week. The postmitotic photoreceptor progenitors (Otx2, 
Crx, and Nrl) were upregulated up to 1 week after transplantation. 
Finally, the mature rod photoreceptor markers peripherin (Rds) and 
rhodopsin (Rho) were upregulated already 72 hours after transplan-
tation, but were very highly expressed within 1 week. Low upregula-
tion of the cone photoreceptor markers Opn1mw and Opn1sw was also 
detected. However, no upregulation of calretinin (Calr, expressed in 
ganglion and amacrine cells) nor of Brn3a, Brn3b (markers of GCs) 
nor of Pkca (a marker of bipolar cells), was detected at any time point, 
which suggests that hybrids were not differentiated toward these 
retinal cell fates. The HSPC (Runx1, Gata1) and MG (Gfap, Cralbp) 
markers were downregulated already 24 hours after transplantation 
(Figure 3A). For the hybrids obtained after the fusion of untreated 
HSPCs, we did not observe upregulation of the above-mentioned 
markers; instead, HSPC (Runx1, Gata1) and MG (Gfap, Cralbp) genes 
were expressed (Supplemental Figure 3B). These data indicated that 
the hybrids formed after fusion of BIO-HSPCs underwent repro-
gramming to a pluripotent/neural progenitor–like fate and then com-
mitted toward photoreceptors in vivo.
To confirm this conclusion, we transplanted BIO-treated or 
untreated HSPCsR26Y in the eyes of MNU-damaged nestin-Cre 
recipient mice (Figure 3B). We observed YFP+ hybrids only after 
transplantation of BIO-HSPCs (Figure 3C), which indicates that 
reactivation of nestin and reprogramming of the hybrids was 
dependent on Wnt activity. Furthermore, upon MNU treatment, 
in 24 hours, photoreceptors start to die (TUNEL+) in retinas 
transplanted with either untreated HSPCs, BIO alone, or vehi-
cle alone (PBS). Instead, a much-reduced number of TUNEL+ 
photoreceptors was seen in BIO-HSPC–transplanted retinas and 
especially in the proximity of YFP+ hybrids (Figure 3C and Sup-
plemental Figure 1, B and C).
We then verified on sections whether Müller-derived hybrids 
can generate photoreceptors. We performed double staining of 
retinal sections 1 week after transplantation of BIO-treated or 
untreated HSPCs in MNU-damaged Gfap-Cre eyes (Figure 4, A 
and B). First, upon HSPC transplantation, we observed only 1 or 
2 leftover nuclear layers in the ONL, and these were negative 
for the expression of recoverin (Figure 4, A and C, and Supple-
mental Figure 4A). The few YFP+ hybrids detected were positive 
for the MG marker GS (Figure 4A). In contrast, after transplan-
tation of BIO-treated HSPCs, we found up to 8 nuclear layers 
in the ONL (Figure 4, B and C, and Supplemental Figure 4A), 
which included hybrids positive for both YFP and recoverin (i.e., 
photoreceptors) (Figure 4B).
Overall, these results show that MG can be efficiently repro-
grammed into photoreceptors upon fusion with BIO- treated 
HSPCs, passing through a proliferating and more dedifferenti-
ated intermediate.
Despite many photoreceptors derived from the proliferation 
and differentiation of reprogrammed MG cells (i.e., BrdU/Rec 
double-positive cells; Figure 4D), not all of the photoreceptors in 
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BIO-HSPC transplanted retinas were derived from the hybrids, as 
not all of them were positive for YFP (Figure 4B) or for BrdU (Fig-
ure 4D), which suggests that newly generated photoreceptors can 
contribute overall to blocking the death of the neighboring ones.
In vivo reprogramming of MG upon fusion with Wnt-activated 
HSPCs can rescue retinal degeneration phenotypes. We next aimed 
to investigate the possible functional rescue of the retinal degen-
eration phenotype due to the photoreceptors derived from the 
hybrids formed by fusion of MG and BIO-treated HSPCs. Although 
MNU-induced photoreceptor cell death is a useful model for study-
ing the effects of therapeutic approaches to treating retinal degen-
eration in the short term, this alkylating drug leads to extensive 
oxidative stress and induction of tumors within 1 month (38, 39). 
Thus, we determined whether MG-derived photoreceptors can 
functionally rescue the photoreceptor degeneration phenotype in 
a type 10 retinal degeneration mouse model (rd10) over the long 
term. This is a model of inherited autosomal recessive retinitis pig-
mentosa, which carries a spontaneous mutation in the rod-specific 
β subunit of cyclic guanosine monophosphate–phosphodiesterase 
(cGMP-phosphodiesterase) (PDE6B). The rd10 mice show pho-
toreceptor dysfunction starting from P18 (i.e., 18 days after birth), 
and full rod photoreceptor degeneration is followed by cone degen-
eration and remodeling of the inner retina by P40 (40).
First, we confirmed the presence of YFP+DiD+ hybrids after trans-
plantation of BIO-treated or untreated DiD-labeled HSPCsVav-Cre 
in the subretinal space of P18 rd10 mice carrying the R26Y trans-
gene (referred to as rd10R26Y) when the degeneration started (Sup-
plemental Figure 5, A and B). YFP+DiD+ hybrids were not detected 
in transplanted WT control retinas, which indicated that rd10 pho-
toreceptor degeneration induced fusion of MG with transplanted 
Figure 5. Regeneration of photorecep-
tors in rd10 mice. (A and B) Represen-
tative immunostainings of YFP+ (green) 
with either GS (red, white arrow) or 
recoverin (red, yellow arrows) in rd10R26Y 
retinas 42 days after transplantation 
of BIO-treated (A) or untreated (B) 
HSPCsVav-Cre. n = 3. (C) Total number of 
YFP+ hybrids (green bars) that incorpo-
rated BrdU (red bars) detected in rd10R26Y 
eyes 24 hours (P19), 72 hours (P21), and 
42 days (P60) after transplantation of 
untreated or BIO-treated HSPCsVav-Cre. 
Data are represented as mean ± SD. 
n = 9. **P < 0.001; *P < 0.01, 2-way 
ANOVA and Bonferroni’s post-test. Red 
and green lines show the statistical 
significance of the difference between 
the respective green (YFP) and red 
(BrdU) bars. (D) Percentages of double 
YFP+BrdU+ hybrids also positive for GS, 
OTX2, or recoverin stainings 42 days 
(P60) after transplantation of untreated 
(gray bars) or BIO-treated ( black bars) 
HSPCsVav-Cre in rd10R26Y retinas. Data are 
represented as mean ± SD. n = 9. (E) 
Representative immunodetection of 
BrdU+ cells (red) also positive for the 
photoreceptor marker recoverin (green) 
in the ONL of MNU-damaged rd10R26Y 
retinas 42 days after transplantation 
of BIO-treated HSPCsVav-Cre. Nuclei were 
counterstained with DAPI (blue). Insert 
shows higher magnification of the 
region in the white square. (F) Repre-
sentative confocal image of YFP+ hybrids 
(green) also positive for BrdU (red) and 
recoverin (blue) in the ONL of rd10R26Y 
retinas 42 days after transplantation of 
BIO-treated HSPCsVav-Cre. Images at the 
bottom represent enlargements of the 
same YFP+ hybrid (green) also positive 
for recoverin (blue in the left panel) and 
for BrdU (red in the right panel) stain-
ings. n = 3. Scale bar: 20 μm.
Downloaded from http://www.jci.org on October 19, 2016.   https://doi.org/10.1172/JCI85193
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
3 1 1 1jci.org   Volume 126   Number 8   August 2016
these hybrids were positive for the MG marker GS and negative 
for recoverin (Figure 5B). Moreover, while only 1 row of nuclei 
in the ONL was detected in rd10 eyes transplanted with untreat-
ed HSPCs, a much higher number of photoreceptor nuclei was 
observed in mice transplanted with BIO-treated HSPCs (Figure 
5, A and B).
We then performed cell-tracing experiments to investigate 
whether the hybrid-derived photoreceptors were generated 
from proliferative events. We followed BrdU+ hybrids after trans-
plantation of BIO-treated and untreated HSPCsVav-Cre in rd10R26Y. 
Activation of Wnt signaling in transplanted HSPCs resulted in an 
increase in the proliferating hybrids at 24 hours (P19), 72 hours 
(P21), and 42 days (P60) after transplantation with respect to the 
corresponding times after HSPC transplantation (Figure 5C). In 
contrast, the YFP+ hybrids decreased after HSPC transplanta-
tion (Figure 5C), which suggests that they underwent cell death 
in the latter case. Brdu+YFP+ hybrids expressed GS after HSPC 
transplantation at 24 hours, 72 hours, and 42 days and therefore 
remained as MG (Figure 5D and Supplemental Figure 5, I and 
J). Instead, after BIO-HSPC transplantation, Brdu+YFP+ hybrids 
progressively silenced GS and expressed OTX2 and recoverin, 
which suggests their differentiation toward a photoreceptor cell 
fate (Figure 5D and Supplemental Figure 5, I and J). Remarkably, 
HSPCs (Supplemental Figure 5, A and B). To confirm fusion with 
MG, we also transplanted HSPCsVav-Cre in P18 rd10R26Y; as expected, 
24 hours after transplantation, the hybrids were immunoreactive 
to the MG marker GS, but not to the photoreceptor marker RHO 
(Supplemental Figure 5, C and D). The hybrids obtained upon 
fusion with BIO-treated HSPCsVav-Cre proliferated (Supplemental 
Figure 5E) and expressed pluripotent/neural progenitor markers 
(Supplemental Figure 5G, see below). In contrast, the YFP+ hybrids 
formed upon transplantation of untreated HSPCsVav-Cre underwent 
apoptosis (Supplemental Figure 5F) and were not reprogrammed 
(Supplemental Figure 5G).
Next, 42 days after transplantation, at P60, we analyzed 
the presence of hybrid-derived photoreceptors. Interestingly, in 
2-month-old rd10 mice transplanted with BIO-treated HPSCs 
isolated from Vav-Cre/CAG-RFP double-transgenic animals 
(where RFP indicates red fluorescent protein; HSPCsVav-Cre/RFP), 
many YFP+RFP+ hybrids were detected in the regions of the ONL, 
including a high number of nuclear rows (Supplemental Figure 
5H). Indeed, 42 days (at P60) after transplantation of BIO-treat-
ed HSPCsVav-Cre, we found YFP+ hybrids that were positive for 
recoverin staining and negative to GS (Figure 5A). In contrast, as 
expected, few YFP+ hybrids were found in HSPC-transplanted 
rd10 retinas of 2-month-old mice. When detectable in sections, 
Figure 6. Functional rescue of the rd10 phenotype upon BIO-treated HSPC transplantation. (A) Representative H&E staining of 2-month-old rd10 retinas 
transplanted with BIO-treated HSPCs in the right eyes or with PBS in the left eyes as control. Scale bar: 20 μm. n = 8. (B) Statistical analysis of the maximum 
number of nuclear rows detected in the ONL of 2-month-old mouse retinas harvested from either WT or rd10 animals transplanted at P18 with BIO-treated 
HSPCs or treated with vehicle alone (PBS) as control. Data are represented as mean ± SEM. n = 8. ***P < 0.0001, unpaired Student’s t test. (C) Statistical 
analysis of the number of ONL nuclei rows detected in the nasal, central, or temporal retinal areas of 2-month-old rd10 right retinas transplanted with 
BIO-treated HSPCs with respect to left control (PBS) eyes. ***P < 0.0001, unpaired Student’s t test. Nine serial sections for each mouse (n = 8) were ana-
lyzed. Counts of 8 retinas out of 21 showed increased nuclear rows and were plotted. (D) Representative ERG responses of 2-month-old rd10 mice trans-
planted in the right eyes with BIO-treated HSPCs (BIO-HSPCs) or with vehicle alone (PBS) in left eyes as control. Data are represented as mean ± SD (n = 8) 
of the A-wave and B-wave amplitudes (µV) of ERG responses from 8 out of 21 treated mice that showed increased ONL thickness upon BIO-treated HSPC 
transplantation. ***P < 0.0001, unpaired Student’s t test. (E) Western blotting of PDE6B protein levels in retinas harvested from either 2-month-old WT or 
rd10 mice treated with PBS or transplanted with BIO-treated HSPCs at P18. Three different BIO-HSPC transplanted retinas were analyzed (no. 1, no. 2, no. 3).
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ed rd10 eyes, while it was present at variable levels in 3 different 
rd10 eyes transplanted with BIO-treated HSPCs (Figure 6E). This 
suggests that WT PDE6B was expressed by the genome of the 
transplanted HSPCs within the hybrids, thereby rescuing the rd10 
phenotype.
In conclusion, our results demonstrate that, upon fusion with 
Wnt-activated HSPCs, MG can be efficiently reprogrammed and 
differentiated into functional photoreceptors in vivo and that this 
might represent a therapeutic strategy for rescuing retinal degen-
eration phenotypes.
Discussion
Retinitis pigmentosa is a family of inherited diseases that cause 
retinal degeneration due to photoreceptor cell death. The rd10 
mouse model reproduces one of the earliest onset and most 
aggressive forms of recessive retinitis pigmentosa, which is due 
to mutations in the Pde6b gene (43, 44). Very limited therapeu-
tic approaches are currently available for the treatment of this 
blindness. Indeed, many efforts have been made to block or delay 
degeneration of photoreceptors (45, 46); however, to date, very 
limited success has been obtained in terms of their regeneration in 
mouse models of retinitis pigmentosa.
Here, we have shown that MG can be reprogrammed in vivo 
and, in turn, efficiently differentiated into photoreceptors via cell 
fusion with HSPCs in a drug-induced model of retinal degenera-
tion and in rd10 mice, provided that Wnt signaling was previously 
activated in the transplanted cells. BrdU+ photoreceptors originat-
ed from the MG-derived hybrids were tracked over the long term, 
i.e., 42 days after transplantation of BIO-HSPCs in rd10 mice. 
On the other hand, we also clearly observed a protective effect of 
the resident photoreceptors upon transplantation of BIO-HSPCs, 
which can be due to hybrid-mediated indirect protection or to a 
direct effect mediated by BIO-HSPC–secreted factors. Therefore, 
the hybrid-derived photoreceptors likely blocked or delayed the 
overall retina degeneration; indeed, not all the surviving photore-
ceptors in the long term after transplantation were YFP positive. 
Some of them were resident photoreceptors that were probably 
protected from cell death. Our data also suggest that, while in the 
degenerated retinas MG appears to extend into the remodeled 
ONL, upon transplantation of BIO-HSPCs, the ONL is regenerat-
ed and MG staining appears in sections as in a WT retina.
We should also consider the possibility that MG phagocytoses 
BIO-HSPCs and that this could result in either regenerative or pro-
tective effect toward the ONL neurons. However, MG cells were 
shown to phagocytose apoptotic retinal cells during development 
(47) as well as apoptotic photoreceptors in degenerated mouse ret-
inas (48, 49). Here, we observed expression of RFP and Pde6b long 
term after transplantation, suggesting that the genome derived 
from donor transplanted BIO-HSPCs is present and is expressed 
in the YFP+ neurons derived from MG; therefore, phagocytosis is 
unlikely to occur in our experimental setting. On the other hand, 
if some BIO-HSPC–transplanted cells are phagocytosed by MG, 
these will just die and will likely not be the cells that regenerate 
the photoreceptors.
Wnt signaling controls regeneration in zebrafish and tad-
poles (19, 50, 51). We have previously shown that ganglion and 
amacrine neurons in the mouse retina can be regenerated by the 
by tracing them, we found a large increase of hybrids positive 
for BrdU in P60 mice, which indicates that they efficiently pro-
liferated and differentiated toward a mature photoreceptor cell 
fate (Figure 5, C, E, and F). Of note, not all of the photoreceptors 
were BrdU+ or YFP+, which suggests that in the rd10 model, as in 
the MNU model, a regeneration process goes along with some 
preservation effect.
We then counted the number of nuclear photoreceptor rows 
across sections. Histological analysis of retinal sections from the 
control left eyes of 2-month-old rd10 mice treated with PBS con-
firmed complete photoreceptor degeneration, with only 1 row 
of photoreceptor nuclei detectable in the ONL (Figure 6, A–C). 
Instead, up to 5 rows of photoreceptor nuclei were detected in 
the ONL of the right eyes of a group of mice transplanted with 
BIO-treated HSPCs, specifically in the temporal area where the 
cells were transplanted (Figure 6, A–C). Of note, no changes were 
detected in either the nuclear row numbers in the inner nuclear 
layer (INL) or in the number of GC nuclei, which suggests that 
treatment with BIO-HSPCs results specifically in the rescue of 
photoreceptor cell loss (Supplemental Figure 6, A–C).
To investigate whether functional rescue of the rd10 pheno-
type was achieved, we recorded scotopic electroretinographic 
(ERG) responses of rd10 dark-adapted right eyes transplanted 
with BIO-treated HSPCs. Left eyes treated with PBS were also 
recorded as controls. Remarkably, we observed that some of the 
retinas transplanted with BIO-treated HSPCs showed record-
able A-waves and B-waves (Figure 6D), albeit these were lower 
than the WT levels (WT A-wave mean [μV] = 416 ± 77 SD; WT 
B-wave mean [μV] = 826 ± 107 SD; n = 4). The A-wave is gen-
erated from functional rod photoreceptors, while the B-wave is 
mainly derived from retinal cells making synapses with photo-
receptors (41). Interestingly, the mice that showed an increase 
in the number of photoreceptor nuclear rows (Supplemental 
Figure 6D) also showed recordable A-waves and B-waves (Sup-
plemental Figure 6E). Instead, the contralateral untransplant-
ed eyes showed completely flat ERG responses (Figure 6D and 
Supplemental Figure 6E).
Similar results were obtained with the rd10R26Y mouse strain, 
where the retinas of mice displaying YFP+ hybrids also showed the 
highest number of rows and were positive for the ERG (Supple-
mental Figure 6, F and G).
Subretinal injection of P18 pups is a challenging chirurgical 
approach, and we therefore observed retinal regeneration in a sub-
set of BIO-HSPC transplanted mice. Therefore, we monitored the 
outcome of the injection by optical coherence tomography (OCT) 
in a different group of rd10-transplanted mice. We confirmed that 
only the group of eyes successfully transplanted with BIO-treated 
HSPCs showed photoreceptor regeneration at the histological lev-
el (Supplemental Figure 6, A–C). In all these mice, the OCT gener-
ated a cataract, and it was not possible to record the ERG.
The ERG A-wave is normally flat in 2-month-old rd10 mice 
because of the absence of PDE6B, which is necessary for the clo-
sure of cGMP-gated cationic rod channels (42). Therefore, we 
analyzed the levels of the PDE6B protein in retinas harvested from 
2-month-old rd10 mice transplanted with untreated or BIO-treat-
ed HSPCs at P18. WT retinas treated with PBS were also analyzed 
as controls. The PDE6B protein was completely absent in untreat-
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We previously showed that upon retinal injury, MG can fuse 
with endogenous mobilized BMDCs (28), which suggests that this 
might also be a physiological response to the damage in mammals 
and lower vertebrates.
In conclusion, we have identified a route to reprogramming 
MG in vivo in order to functionally regenerate photoreceptors in a 
mouse model of retinitis pigmentosa. This approach can be poten-
tially exploited in the future for the treatment of patients.
Methods
Animal care and treatment. In this study, we used the following male 
and female transgenic mice: Vav-Cre (58), CAG-RFP (59), Gfap-Cre 
(60), R26Y (61), RHO-Cre (32), Calr-Cre (33), and nestin-Cre (62). 
Mice were purchased from Jackson Laboratory. R26Y mice were 
a gift of M. Studer (Institute of Biology Valrose, Nice, France). For 
MNU-induced photoreceptor degeneration, adult recipient mice (8 to 
12 weeks old) were treated with an i.p. dose of sterile MNU (60 mg/
kg body weight; Sigma-Aldrich) 24 hours before cell transplantation. 
For BrdU tracking of proliferating hybrids, mice were treated with a 
2 i.p. dose of BrdU (15 mg/kg) every 12 hours, with the first pulse at 
the moment of the cell transplantation. Mice were maintained under 
a 12-hour light/12-hour dark cycle, with access to food and water ad 
libitum. For the whole study, animals were randomly assigned to treat-
ment groups. We chose groups of a minimum of 6 mice because that 
was the minimal number of animals required for reaching statistical 
significance. General anesthesia was induced when needed with i.p. 
injections of ketamine (70 mg/kg, Imagene; Merial) and medetomi-
dine (10 mg/kg, Domitor; Pfizer Animal Health).
HSPC isolation and treatment. Donor adult mice (8 to 12 weeks old) 
were sacrificed by cervical dislocation, and total BM was flushed out 
from femurs and tibia. HSPCs (Lin–) were purified from total BM cells 
by untouched isolation on a magnetic sorter using the Lineage Deple-
tion Kit (Miltenyi Biotec) according to the manufacturer’s protocol. 
Cells were cultured in StemSpan SFEM medium (STEMCELL Tech-
nologies) at a concentration of 1 × 106 cells/ml in the presence of 100 
ng/ml recombinant mouse SCF (R&D Systems), 20 ng/ml mouse IL-3 
(Peprotech), 20 ng/ml human IL-6 (Peprotech), and 10 ng/ml FLT3 
ligand (Peprotech). Cells were treated with 1 μM BIO (Calbiochem) for 
24 hours or untreated as control before transplantation. Thirty min-
utes before transplantation, cells were incubated with Vybrant DiD 
Cell-Labeling Solution (Life Technologies) for 30 minutes when nec-
essary, washed twice in PBS, and resuspended to a final concentration 
of 1 × 105 cell/μl for transplantation.
Subretinal transplantation of cells. Anesthetized recipient animals 
received a single 1 μl administration of HSPC suspension (1 × 105 cells/
μl) by subretinal route. Injections were performed under an operating 
microscope (Zeiss OPMI Pico; Carl Zeiss Meditec GmbH) with the 
aid of a 5-μl Hamilton microsyringe (Hamilton Co.). Each mouse was 
kept on a 37°C pad after it was anesthetized, during and after surgery. 
Briefly, a scalpel was used to make a small cut through the sclera in a 
temporal position. Then, a 33-gauge bevelled (45°) needle located on 
a Hamilton syringe system was inserted in the hole between the epi-
thelium and the retina with a tangential angle with the flat part of the 
bevel toward the retinal side. Cell suspension was injected with a slow 
and constant pressure. The needle was left in position for another 5 
to 10 seconds to allow pressure in the injection system to equilibrate 
with the eye pressure and then removed by slowly pulling backwards 
hybrids formed after Wnt-activated HSPCs (28). How is it possi-
ble that the hybrids can generate either photoreceptors, GCs, or 
amacrine neurons? It appears likely that this is dependent on the 
signaling pathway induced, on the type of damaged cells in need 
of being replenished, and also on the site of injection. Here, we 
transplanted HSPCs very close to the photoreceptor layer; we 
also attempted transplantation in the vitreous, but we did not 
observe regeneration. Furthermore, transplantation at late times, 
when the ONL was completely lost, was not effective in rescuing 
the increase in nuclear rows in the ONL, which indicates that it 
is essential to transplant mice when some photoreceptors are still 
present. A fully degenerated photoreceptor layer cannot be revert-
ed, which indicates that the time of intervention is critical. How-
ever, in human pathology, where degeneration is much slower 
than in rd10 mice, it is possible that the time window to transplant 
the cells will be considerably larger. It is also worth considering 
that different signals can be activated by damaged neurons and 
they can induce alternative differentiation responses; for exam-
ple, MG regenerates photoreceptors when these specific cells are 
destroyed in goldfish (52). These signals might in principle be tar-
geted to enhancing the efficacy of the therapy.
In vitro–generated neurons after transdifferentiation of 
somatic cells are an exciting tool for regenerative medicine; how-
ever, engraft problems are a bottleneck for this approach. Strat-
egies based on in vivo conversion of resident cells through the 
overexpression of key transcription factors might overcome this 
limitation; nevertheless, to reach clinical applications, it is imper-
ative to obtain a safe in vivo delivery system to specifically tar-
get cells where the expression of reprogramming factors can be 
turned off. In this context, cell fusion with endogenous glial cells 
represents a promising therapeutic approach that might over-
come all of these hurdles. Fusion of transplanted HSPCs might 
be used to deliver a specific combination of key factors to the 
targeted cells, once shown to be efficient for inducing conversion 
of MG into functional photoreceptors. Alternatively, HSPCs can 
deliver WT alleles after fusion with MG carrying recessive muta-
tions, therefore providing a transversal strategy to correct genetic 
defects in a variety of patients. HSPCs have also been shown to 
stabilize retinal blood vessels in rd10 mice, thereby providing a 
neurotrophic beneficial effect for the preservation of the retinal 
nuclear layers (53). Importantly, clinical trials have already shown 
the safety of HSPCs (54).
Still, some questions remain open in our studies. We observed 
some single-color hybrids (only YFP+), which indicates silencing 
of the RFP transgene or ploidy reduction. We previously showed 
that in vivo–formed hybrids appear as synkaryons or heterokary-
ons, thereby containing 1 or 2 nuclei (28). Multipolar mitosis with 
ploidy reduction of hybrids was seen in the liver after fusion of 
hepatocytes with BMDCs (55). On the other hand, heterokaryons 
have been found in the CNS after BM transplantation (56), which 
indicates that neurons can cope with high ploidy content.
Here, we also provided evidence that Wnt activation increas-
es the proliferation potential and survival of the hybrids, which in 
turn downregulate the 2 cell-cycle regulators p27Kip1 and p57Kip2. 
These 2 factors control retinal progenitor cell-cycle exit and differ-
entiation during retinal development (14). Interestingly, p27Kip1 is 
downregulated very early in MG in regenerating fish retinas (57).
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Green qPCix-UDG (Invitrogen) were performed in an LightCycler 
480 (Roche) real-time PCR machine according to the manufacturer’s 
recommendations. The oligos used are listed in Supplemental Table 
1. Runx1 and Gata1 oligos were purchased from QIAGEN. All of the 
experiments were performed in triplicate, and differences in cDNA 
input were compensated by normalizing to the expression of Gapdh. 
Relative mRNA levels were evaluated as the fold changes with respect 
to the untreated control or to retinal samples depleted by sorting of 
either the double DiD+YFP+ or RFP+YFP+ hybrid population.
Fixing, sectioning, immunohistochemistry, and Western blotting. 
Eyes were fixed by immersion in 4% paraformaldehyde overnight and 
then embedded in paraffin. Serial transversal sections of 10-μm thick-
ness were processed for TUNEL staining (In Situ Cell Death Detec-
tion Kit, Roche) according to the manufacturer’s protocol. For immu-
nostaining, sections were treated with serial washing in Xilene for 2 
minutes, EtOH 100% for 1 minute, EtOH 95%  for 1 minute, EtOH 90 
for 1 minute, EtOH 80% for 1 minute, EtOH 70% for 1 minute, EtOH 
50% for 1 minute and H2O. Slices were placed in a plastic rack with 
an antigen retrieval buffer (NaCitrate 0.1 M Triton X-100 0.1%) and 
boiled for 4 minutes in a domestic microwave oven. After a wash with 
cold water, sections were blocked in NGS 10% for 30 minutes and 
NGS 1% for 30 minutes. Primary antibodies were incubated in PBS 
overnight at 4°C. The primary antibodies used were as follows: rabbit 
anti-glutamine synthetase GS (1:300, Sigma-Aldrich, G-2781) mouse 
anti-PCNA (1:200, Sigma-Aldrich, P8825), chicken anti-GFP (1:500, 
Abcam, AB13970), rabbit anti-recoverin (1:500, Millipore, AB5585), 
mouse anti-BrdU (1:200, Sigma-Aldrich, B8434), rabbit anti-OTX2 
(Abcam, AB21990), rabbit anti-calbindin D-28K (1:50, Sigma-Aldrich, 
C7354), mouse anti-calretinin (1:100, Millipore, MAB1568), mouse 
anti–SMI-32 (1:100, Millipore, NE1023), rabbit anti–PKC-α (1:200, 
Abcam, AB32376), and mouse anti–β-tubulin III (clone TU-20, Mil-
lipore, MAB1637). The secondary antibodies used were as follows: 
anti-chicken Alexa Fluor 488 (1:1000; Molecular Probes, Invitro-
gen), anti-chicken Alexa Fluor 568 (1:1000; Molecular Probes, Invi-
trogen), anti-mouse Alexa Fluor 568 (1:1000; Molecular Probes, 
A11031, Invitrogen), anti-rabbit Alexa Fluor 568 (1:1000; Molecular 
Probes, A11036, Invitrogen), anti-mouse Alexa Fluor 633 (1:1000; 
Molecular Probes, A21050, Invitrogen), and anti-rabbit Alexa Flu-
or 633 (1:1000; Molecular Probes, A21070, Invitrogen). Nuclei were 
counterstained with DAPI (Vectashield, Vector Laboratories). Photo-
graphs were taken using either an Axioplan microscope (Zeiss) or a 
Leica laser SP5 or SPE confocal microscopy systems.
For Western blotting, whole cell lysates were prepared by resus-
pending retinas in 20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM 
MgCl2, 0.1 mM CaCl2, 10% glycerol, 0.1% Triton X-100, and prote-
ase inhibitors (phenylmethylsulfonyl fluoride and cOmplete prote-
ase inhibitor cocktail; Roche Molecular Biochemicals), followed by 
syringing through a 23-gauge needle. Cell lysates (30 μg/lane) were 
electrophoresed through a 10% polyacrylamide-SDS gel and pro-
teins transferred to a polyvinylidene difluoride (PVDF) membrane. 
Membranes were immunostained overnight at 4°C with primary anti-
PDE6β (1:500, Abcam AB5663) and anti–β-actin (1:5,000, Abcam 
AB8226) antibodies and 1 hour at room temperature with secondary 
anti-mouse IgG (1:2000, GE HealthCare, NA931V) and anti-rabbit 
IgG (1:2000, GE HealthCare, NA934V) antibodies. The signal was 
visualized using Pierce ECL Western Blotting Substrate (Thermo Sci-
entific) chemiluminescence detection systems.
to allow the hole in the retina to reseal and to avoid damaging the ret-
ina and corneal endothelium during removal.
OCT. To further confirm the correct delivery of the cells in the 
subretinal space, noninvasive in vivo assessment of retinal detach-
ment formed upon subretinal injections was performed by OCT of 2 
groups of mice (group 1, n = 12; group 2, n = 16; 4 different litters in 
total) subretinally injected by 2 different operators. Two independent 
experiments were sufficient to confirm the same percentage of success 
of the subretinal injection procedure (32.2%). For this purpose, groups 
with different variances were compared. The assessment was per-
formed when mice were under general anesthesia as described in the 
Animal care and treatment section. Combined confocal scanning laser 
ophthalmoscopy (cSLO) and SD-OCT imaging were performed using a 
commercially available device (Spectralis HRA OCT system, Spectralis 
Eye Explorer 5.6b, Heidelberg Engineering). To adapt the system to the 
mouse eye, a commercially available +25D lens was fit to the system 
(Heidelberg lens, HE 50744) and the length of the reference pathway 
was manually adapted according to the manufacturer’s instructions. 
The cSLO system used was an HRA2, using solid source for 488 and 
514 nm and an infrared diode laser for 785 and 815 wavelengths. In 
order to improve the image acquisition quality, mice wore a PMMA 
afocal contact lens, with a radius and diameter of 2.7 mm, respective-
ly. Contact lenses were purchased from Cantoor Nissel (Market Place 
Brackley). Tear substitutive drops were continuously added to improve 
transparence (Systane, Alcon Labs). Mice were analyzed for cSLO/
SD-OCT with a single scan looking for the injection site.
The correlation analysis between the positive delivery of cells in 
the subretinal space and the increase in the number of nuclear rows 
in the ONL, INL, and GC layer (GCL) was carried out blindly before 
inspection of the histological results.
Electroretinogram tests. For the ERG tests, treated 2-month-old 
mice were dark adapted for 3 hours, anesthetized, and placed in a ste-
reotaxic apparatus under dim red light. ERGs were evoked by flashes 
of different light intensities ranging from 10–4 to 20 cd m–2 s–1 generat-
ed through a Ganzfeld stimulator (Lace Elettronica). Three different 
responses evoked by light were averaged for each luminance step to 
minimize the noise. The electrophysiological signals were recorded 
through gold plate electrodes inserted under the lower eyelids referred 
to a needle electrode inserted s.c. at the level of the corresponding 
frontal region. The different electrodes were connected to a 2-channel 
amplifier. The amplitudes of the A- and B-waves measured for each 
eye upon stimulus with the higher intensity flash under scotopic con-
dition were plotted.
Hybrid isolation for gene expression and flow cytometry analysis. For 
FACS analysis, retinal samples were isolated, disaggregated in trypsin 
by mechanical trituration, and filtered. Samples were analyzed by flow 
cytometry in an LSR I instrument or LSR Fortessa (BD) with FlowJo 
(Tree Star Inc.) or FACSDiva (BD) software in order to assess the per-
centage of DID+YFP+ hybrids. In all samples, DAPI (Sigma-Aldrich) 
was added to exclude dead cells from the analysis.
For gene expression analysis, a BD FACSAria II sorting machine 
(BD) was used to isolate either the double DiD+YFP+ or RFP+YFP+ 
hybrids. DAPI (Sigma-Aldrich) was added to exclude dead cells. 
Total RNA was extracted using RNA Isolation Mini or Micro Kits 
(QIAGEN) according to the manufacturer’s protocol. The eluted 
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